Search

It’s not very often that we come across a researcher working on a project inspired by their own lived experience of a sight loss condition.

• Case study - research
• Written

A discovery made as part of research funded by Retina UK has led to a prestigious award of $2.5 million, enabling scientists to undertake more in-depth investigations and work towards a treatment for a particular type of retinitis pigmentosa.

• News

Biotechnology company MeiraGTx has announced encouraging news from its phase 1/2 clinical trial of botaretigene sparoparvovec (previously known as AAV-RPGR), a gene therapy aimed at X-linked retinitis pigmentosa caused by faults in the RPGR gene.

• News
• Retinitis pigmentosa

It is important to avoid harming your vision, particularly if you have an inherited sight loss condition.

Our Keynote speaker will be Mr Kanmin Xue. Mr Xue is a Consultant Vitreo-retinal Surgeon at the John Radcliffe Hospital and Wellcome Trust clinician scientist fellow at the University of Oxford where he leads the Retinal Disease and Repair Group.

• Information event
• Audio
• Written

Retina UK invites expressions of interest for their inaugural career development grant call, which will result in an award of up to £1million as a strategic and targeted investment to result in a transformative impact for therapy for inherited retinal dystrophy.

Dr Graham undertook research into the basic mechanisms of retinal vasculitis, inflammation of the blood vessels in the retina, and is an important cause of poor vision in patients with uveitis, inflammation of the uveal tract.

• Trustee
• Written

Hajrah Sarkar is a PhD student whose project is funded by Retina UK.

• Case study - research
• Written

The project aims to develop a cost effective method of examining the entire ABCA4 gene to look for variations that might cause disease.

• Case study - research
• Written

Fancy fundraising for Retina UK? Here’s a few pointers to help get you started.